Science Explorer Interactive view Map

Puma Biotechnology (United States)

Research works
80
▲ 393% vs 2013–17
Citations
1.3k
16.5 per fractional work
Top-10% rate
13.8%
record average 16.5%
Open access
38%
world 28%

Not ranked overall: Puma Biotechnology (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 4.12× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 2.49× its world share, 0 worksImmunology and Micro…Neuroscience: 0.19× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 1.34× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.80× its world share, 0 worksChemistryComputer Science: 0.10× its world share, 0 worksComputer ScienceEngineering: 0.38× its world share, 1 worksEngineeringMaterials Science: 0.27× its world share, 0 worksMaterials ScienceMathematics: 0.13× its world share, 0 worksMathematicsPhysics and Astronomy: 0.28× its world share, 0 worksPhysics and AstronomyMedicine: 3.15× its world share, 11 worksMedicineNursing: 6.40× its world share, 1 worksNursingDecision Sciences: 1.14× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.28× its world share, 0 worksEconomics, Econometr…world share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Nursing, 6.4×. Every wedge is a field page.

Who are the top researchers at Puma Biotechnology (United States)?

Ranked on the composite score, Alshad S. Lalani and Richard Bryce lead among researchers whose main affiliation is Puma Biotechnology (United States).

  1. 1 Alshad S. Lalani United States · #439,722 worldwide 76 citations · 17 works
  2. 2 Richard Bryce United States · #704,484 worldwide 36 citations · 21 works
All ranked researchers at Puma Biotechnology (United States)

Which keywords describe research at Puma Biotechnology (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Breast Cancer, Chemotherapy, Metastatic Breast Cancer, Metastatic, Monoclonal Antibody, Trastuzumab, EGFR and HER2.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Breast Cancer20▲ 90×5 topics
  2. Chemotherapy14▲ 25×10 topics
  3. Metastatic Breast Cancer12▲ 220×2 topics
  4. Metastatic10▲ 205×2 topics
  5. Monoclonal Antibody10▲ 186×2 topics
  6. Trastuzumab10▲ 300×2 topics
  7. EGFR10▲ 423×1 topic
  8. HER210▲ 423×1 topic
  9. Cell Cycle Control9▲ 461×2 topics
  10. CDK4/6 Inhibitors9▲ 712×1 topic
  11. Palbociclib9▲ 712×1 topic
  12. Targeted Therapy6▲ 34×4 topics
  13. Clinical Trials5▲ 9.7×5 topics
  14. Genomic Profiling4▲ 48×2 topics
  15. ALK Inhibitors4▲ 82×1 topic
  16. EGFR Mutations4▲ 82×1 topic
  17. Prognostic Factors4▲ 10.0×8 topics
  18. Cancer3▲ 3.0×14 topics
  19. Glycosylation3▲ 19×3 topics
  20. Survival Analysis3▲ 15×5 topics
  21. Clinical Practice Guidelines3▲ 7.0×6 topics
  22. Fc Receptors3▲ 36×1 topic
  23. Quality of Life3▲ 2.7×4 topics
  24. Therapeutic Antibodies3▲ 28×1 topic
  25. Cancer Therapy3▲ 5.2×9 topics
  26. Immunotherapy3▲ 5.1×10 topics
  27. Molecular Subtypes3▲ 39×2 topics
  28. Chemotherapy-Induced Peripheral Neuropathy3▲ 65×1 topic
  29. Taxanes3▲ 65×1 topic
  30. Rituximab2▲ 18×2 topics
  31. Chronic Lymphocytic Leukemia2▲ 52×1 topic
  32. Gene Expression2▲ 4.2×5 topics
  33. Genomic Aberrations2▲ 52×1 topic
  34. Signaling2▲ 20×2 topics
  35. Genomic Instability2▲ 18×2 topics
  36. Neoadjuvant Therapy2▲ 10×2 topics
  37. Population Dynamics2▲ 6.9×3 topics
  38. Breast Tumours2▲ 38×1 topic
  39. Cancer Genomics2▲ 34×1 topic
  40. Treatment Response2▲ 38×1 topic

Which research topics does Puma Biotechnology (United States) publish most on?

By volume in 2022–2025: HER2/EGFR in Cancer Research, Advanced Breast Cancer Therapies, Monoclonal and Polyclonal Antibodies Research and Breast Cancer Treatment Studies.

  1. 1 HER2/EGFR in Cancer Research Oncology 2 works
  2. 2 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 2 works
  3. 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  4. 4 Breast Cancer Treatment Studies Cancer Research 1 works
  5. 5 Cancer Treatment and Pharmacology Oncology 0 works
  6. 6 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works
  7. 7 Infant Nutrition and Health Nutrition and Dietetics 0 works
  8. 8 Glycosylation and Glycoproteins Research Molecular Biology 0 works
  9. 9 Lower Extremity Biomechanics and Pathologies Biomedical Engineering 0 works
  10. 10 Chronic Lymphocytic Leukemia Research Genetics 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available38.1%not open61.9%

World: 28% of research is openly available.

with international co-authors45.7%domestic only54.3%

World: 19% is written across borders.

How has Puma Biotechnology (United States)'s research output changed?

Output in 2018–2022 was 393% higher than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Los Angeles

All research institutions in Los Angeles

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.